All News #Library
Biotech
Vittoria Bio Presents VIPER-101 Phase 1 Data At ASH 2025
10 Nov 2025 //
GLOBENEWSWIRE
Vittoria Biotherapeutics Shares VIPER-101 Trial at ASCO 2025
28 May 2025 //
GLOBENEWSWIRE
Vittoria Bio Doses 1st Patient in VIPER-101 Phase 1 Trial
19 Dec 2024 //
GLOBENEWSWIRE
Vittoria Bio Presents Preclinical CAR-T Data at ASH 2024
09 Dec 2024 //
GLOBENEWSWIRE
Vittoria Bio Announces Presentations at 66th ASH Annual Meeting
25 Nov 2024 //
GLOBENEWSWIRE
Vittoria Bio Completes $25 Million Financing for Cell Therapies
12 Nov 2024 //
GLOBENEWSWIRE
Vittoria Bio Announces FDA Clearance of IND Application for VIPER-101
07 Dec 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support